文献速递关节外科

慢性血小板减少症与初次全髋和全膝关节置换术后院内结局

Chronic Thrombocytopenia and In-Hospital Outcomes After Primary Total Hip and Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2021-09-04

基于2005至2015年全美住院患者样本,纳入578,278例初次全髋置换和1,237,331例初次全膝置换患者,分析慢性血小板减少症(cTCP)对术后结局的影响。cTCP比例在全髋和全膝置换中分别年增6.95%和6.66%;cTCP与全髋置换医疗及手术并发症风险升高相关,与全膝置换死亡、医疗及手术并发症风险升高相关,并伴随更高费用和更长住院时间。

要点

  • cTCP在全髋和全膝置换患者中的比例分别年增6.95%和6.66%。
  • 全髋置换伴cTCP者医疗并发症OR 2.00,手术并发症OR 2.72。
  • 全膝置换伴cTCP者死亡OR 1.68,医疗并发症OR 1.94,手术并发症OR 2.55。

核心结论

  • cTCP患者在全膝置换中死亡风险更高,在全髋和全膝置换中围手术期并发症风险均更高。

研究设计与样本

  • 回顾性分析2005至2015年Nationwide Inpatient Sample数据库,纳入初次全髋置换578,278例和初次全膝置换1,237,331例,比较伴与不伴cTCP患者。

主要发现

  • cTCP比例在全髋置换中年增6.95%,在全膝置换中年增6.66%。
  • 全髋置换伴cTCP者医疗并发症OR 2.00(95%CI 1.89-2.11),手术并发症OR 2.72(95%CI 2.55-2.90)。
  • 全膝置换伴cTCP者死亡OR 1.68(95%CI 1.22-2.31),医疗并发症OR 1.94(95%CI 1.85-2.03),手术并发症OR 2.55(95%CI 2.38-2.73)。
  • 两种手术伴cTCP者均观察到更高费用和更长住院时间。

临床怎么用

  • 对拟行初次全髋或全膝置换的患者,应识别慢性血小板减少症以评估围手术期并发症和死亡风险。
  • 伴cTCP患者需关注更高医疗费用和更长住院时间,优化术前管理可能改善结局。

局限性

  • 原文未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a lack of data on the influence of chronic thrombocytopenia (cTCP) on clinical outcomes following primary total hip arthroplasty (THA) and total knee arthroplasty (TKA). Limited studies mainly focused on postoperative heparin-induced TCP from single centers with small sample sizes. This study aims to describe the characteristics, trend, and outcomes of cTCP in patients undergoing THA and TKA from a nationally reprehensive perspective. METHODS: We identified THA and TKA patients with and without cTCP from the 2005 to 2015 Nationwide Inpatient Sample. Annual percent changes were calculated to reflect cTCP trends. Multivariable regression and propensity score analyses were conducted to investigate the association of cTCP and mortality, preoperative complications, cost as well as length of stay. RESULTS: In total, 578,278 and 1,237,331 patients underwent primary THA and TKA, respectively. Proportion of cTCP annually increased by 6.95% in THA and 6.66% in TKA. Patients with cTCP were associated with higher risk of medical (odds ratio [OR] 2.00, 95% confidence interval [CI] 1.89-2.11) and surgical complications (OR 2.72, 95% CI 2.55-2.90) in THA, and higher risk of mortality (OR 1.68, 95% CI 1.22-2.31), medical (OR 1.94, 95% CI 1.85-2.03) and surgical complications (OR 2.55, 95% CI 2.38-2.73) in TKA. Additionally, higher cost and longer length of stay were observed in patients with cTCP for both surgical procedures. CONCLUSION: Patients with cTCP had higher risk of mortality for TKA, more perioperative complications for both TKA and THA. Further studies are warranted to improve the preoperative management and to prevent worse outcomes associated with cTCP.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Wang Y, Zhang Y, Wang Y, et al. Chronic Thrombocytopenia and In-Hospital Outcomes After Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2021. PMID: 34563435. doi:10.1016/j.arth.2021.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。